<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Oncology</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Oncology</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский онкологический журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1028-9984</issn><issn publication-format="electronic">2412-9119</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">40011</article-id><article-id pub-id-type="doi">10.17816/onco40011</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Criteria for the definitive diagnosis of melanoma, by creation of a scorecard</article-title><trans-title-group xml:lang="ru"><trans-title>Критерии окончательного диагноза меланомы кожи путем создания единой учетнойкарты</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Yargunin</surname><given-names>S. A</given-names></name><name xml:lang="ru"><surname>Яргунин</surname><given-names>Сергей Анатольевич</given-names></name></name-alternatives><bio xml:lang="ru"><p>канд. мед. наук, зав. отд-нием хирургии опухолей кожи и мягких тканей</p></bio><email>sdocer@rambler.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Davidenko</surname><given-names>I. S</given-names></name><name xml:lang="ru"><surname>Давиденко</surname><given-names>Ирина Сергеевна</given-names></name></name-alternatives><bio xml:lang="ru"><p>заведующая отделением химиотерапии, доктор медицинских наук</p></bio><email>newfolder@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Clinical Oncological Center No1 of Health Department of Krasnodar Region</institution></aff><aff><institution xml:lang="ru">ГБУЗ "Клинический онкологический диспансер № 1" Департамента здравоохранения Краснодарского края</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2013-06-15" publication-format="electronic"><day>15</day><month>06</month><year>2013</year></pub-date><volume>18</volume><issue>3</issue><issue-title xml:lang="en">NO3 (2013)</issue-title><issue-title xml:lang="ru">№3 (2013)</issue-title><fpage>49</fpage><lpage>52</lpage><history><date date-type="received" iso-8601-date="2020-07-22"><day>22</day><month>07</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2013, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2013, ООО "Эко-Вектор"</copyright-statement><copyright-year>2013</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">ООО "Эко-Вектор"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://rjonco.com/1028-9984/article/view/40011">https://rjonco.com/1028-9984/article/view/40011</self-uri><abstract xml:lang="en"><p>Melanoma of a skin is thought to be one of the most aggressive tumors with unpredictable prognosis because of a high potency of local growth, local and remote metastases, and dissemination. Regarding this point very important aspect is an adequate assessment of patients and proper therapy administration according to a disease stage. Options for effective diagnosis is to create a single user registration card will allow to create the uniform Russian Federation register of patients with a skin melanoma and will help to introduce an international treatment standard with distribution of patients on stages and substages.</p></abstract><trans-abstract xml:lang="ru"><p>Меланому кожи относят к одной из самых агрессивных опухолей с непредсказуемым прогнозом из-за высокой потенции местного роста, регионарного метастазирования, способности к диссеминации и отдаленному метастазированию. В связи с этим очень важным моментом является адекватное обследование пациентов и назначение терапии согласно стадии заболевания. Вариантом эффективного установления диагноза является создание единой учетной регистрационной карты и Единого российского реестра больных с меланомой кожи, что также поможет внедрить международные стандарты лечения с учетом распределения пациентов по стадиям и подстадиям.</p></trans-abstract><kwd-group xml:lang="en"><kwd>melanoma of a skin</kwd><kwd>morfo-statistical assessment</kwd><kwd>early diagnostics</kwd><kwd>malignant neoplasms</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>меланома кожи</kwd><kwd>ранняя диагностика</kwd><kwd>морфологическая оценка</kwd><kwd>злокачественные новообразования</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Давыдов М.И., Аксель Е.М. Статистика злокачественных новообразований в России и странах СНГ в 2007 г Вестник РОНЦ им. Н.Н. Блохина. 2009; 20( 3): 2.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Мерабишвили В.М., Чепик О. Ф. Анализ выживаемости и погодичной летальности больных злокачественной меланомой кожи на популяционном уровне. Вопросы онкологии. 2006; 52 (4): 385-91.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Allen D.C. Histopathology reporting. 2-nd Ed. ; 2006: 200-9.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Balch C.M. Cutaneous melanoma: prognosis and treatment results worldwide. Semin. Surg. Oncol. 1992; 8: 400-14.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Balch C.M., SoongS.J., Murad T.M. et al. A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann. Surg. 1981; 193: 377-88.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Batistatou A., Cook M.G., Massi D. Histopathology report of cutaneous melanoma and sentinel lymph node in Europe: a web-based survey by the Dermatopathology Working Group of the European Society of Pathology. Virchows Arch. 2009; 454 (5): 505-11.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Buzaid A.C., Ross M.I., Balch C.M. et al. Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J. Clin. Oncol. 1997; 15: 1039-51.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Carli P. et al. Campagna per la diagnosis precode del melanoma. Quanto e efficace lazione di ''filtro'' del medico di famiglia? G. Ital. Dermatol. Venereol. 1998; 133( 6): 405-10.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Clark W.H., Elder D.E., Guerry D. et al. Model predicting survival in stage I melanoma based on tumor progression. J. Natl. Cancer Inst. 1989; 81: 1893-904.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Compton C.C., Barbill R., Wick M.R., Balch C. Protocol for the examination of specimen from patients with melanoma of the skin. Arch. Pathol. Lab. Med. 2003; 127: 1253-60.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Rivers J.K. Melanoma. Lancet. 1996; 347: 803-7.</mixed-citation></ref></ref-list></back></article>
